Abstract Background Helicobacter pylori (H. pylori) infection contributes significantly to gastric cancer (GC) progression. The intrinsic mechanisms of H. pylori‐host interactions and their role in promoting GC progression need further investigation.
Bing He+10 more
wiley +1 more source
Choroidal Metastasis in Stage IV Lung Adenocarcinoma. [PDF]
Icoz M, Tasci YY, Yorgun MA, Toklu Y.
europepmc +1 more source
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan+13 more
wiley +1 more source
Transmembrane mucins in lung adenocarcinoma: understanding of current molecular mechanisms and clinical applications. [PDF]
Li X+8 more
europepmc +1 more source
Abstract Background Tumor‐associated neutrophils (TANs) play a critical role in modulating immune responses and exhibit significant heterogeneity. Our previous study demonstrated that jagged canonical Notch ligand 2 (JAG2)+ TANs were associated with an immunosuppressive microenvironment in high‐grade serous ovarian cancer (HGSOC), but the underlying ...
Chenyang Wang+11 more
wiley +1 more source
Comprehensive pan-cancer analysis of CHRDL1 and experimental validation of its role in lung adenocarcinoma. [PDF]
Ou G+10 more
europepmc +1 more source
FAM207A acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immunesuppressive tumor microenvironment. [PDF]
Wang L+6 more
europepmc +1 more source
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma. [PDF]
Zhang S+6 more
europepmc +1 more source
The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma. [PDF]
Xu C+7 more
europepmc +1 more source
Intratumor heterogeneity related signature for clinical outcome and immunotherapy advantages in lung adenocarcinoma. [PDF]
Zuo Y, Lin L, Sun L.
europepmc +1 more source